Heron Therapeutics' market cap has risen to ~$360 million, trading at ~$2.38, since my last Hold rating in November 2024.
Amongst the numerous Hayao Miyazaki films, only one deserves the Academy Awards more than The Boy and the Heron.
Heron Therapeutics (NASDAQ:HRTX – Get Free Report) will likely be releasing its earnings data before the market opens on Tuesday, March 11th. Analysts expect Heron Therapeutics to post earnings of ($0 ...
the 82-year-old Japanese anime master is No. 1 at the North American box office. Miyazaki’s latest enchantment, “The Boy and the Heron,” debuted with $12.8 million, according to studio ...
Equities researchers at Northland Capmk issued their Q1 2025 earnings estimates for Heron Therapeutics in a research note ...
Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare ...